In terms of mechanistic studies, it has been found that ABC transporters affect tumor drug resistance through multiple signaling pathways, such as PI3K/Akt, NF-κB, Nrf2, Wnt/β-catenin, and JNK [144,145,146,147,148]. Here, ABCG2 is linked to neoplasm.